down arrow

Brainsway Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011007189
  • TAE: BWAY
ILS
40.00
36.93 (1202.93%)

Sep 24

TAE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Brainsway Ltd.

Why is Brainsway Ltd. ?

1
High Debt company with Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 18.12% and Operating profit at 36.76% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 1.21% signifying low profitability per unit of shareholders funds
2
With ROE of 12.12%, it has a Very Expensive valuation with a 7.05 Price to Book Value
  • Over the past year, while the stock has generated a return of 62.17%, its profits have risen by 101.2% ; the PEG ratio of the company is 0.6
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Brainsway Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Brainsway Ltd.
-100.0%
16.11
45.32%
Israel TA-100
33.07%
1.90
18.41%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
18.12%
EBIT Growth (5y)
36.76%
EBIT to Interest (avg)
-9.78
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.11
Sales to Capital Employed (avg)
0.77
Tax Ratio
2.36%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
14.72%
ROE (avg)
1.21%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
58
Industry P/E
Price to Book Value
7.05
EV to EBIT
80.18
EV to EBITDA
62.42
EV to Capital Employed
26.46
EV to Sales
8.07
PEG Ratio
0.62
Dividend Yield
NA
ROCE (Latest)
32.99%
ROE (Latest)
12.12%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Footer loading
Brainsway Ltd. (BWAY) Stock Recommendation | Score, Valuation, Technicals & Financial Trend